Bibliographic Citation
| - Kaufman Jonathan, Gasparetto Cristina, Schjesvold Fredrik, Moreau Philippe, Touzeau Cyrille, Facon Thierry, Boise Lawrence, Jiang Yanwen, Yang Xiaoqing, Dunbar Fengjiao, Vishwamitra Deeksha, Unger Stefanie, Macartney Tammy, Pesko John, Yu Yao, Salem Ahmed, Ross Jeremy, Hong Wan‐jen, Maciag Paulo, Pauff James, Kumar Shaji. Targeting BCL ‐2 with venetoclax and dexamethasone in patients with relapsed/refractory t(11;14) multiple myeloma. American Journal of Hematology, Wiley, 2021, 96 (4), pp.418 - 427. ⟨10.1002/ajh.26083⟩
- Kaufman Jonathan, Gasparetto Cristina, Schjesvold Fredrik, Moreau Philippe, Touzeau Cyrille, Facon Thierry, Boise Lawrence, Jiang Yanwen, Yang Xiaoqing, Dunbar Fengjiao, Vishwamitra Deeksha, Unger Stefanie, Macartney Tammy, Pesko John, Yu Yao, Salem Ahmed, Ross Jeremy, Hong Wan‐jen, Maciag Paulo, Pauff James, Kumar Shaji . Targeting BCL ‐2 with venetoclax and dexamethasone in patients with relapsed/refractory t(11;14) multiple myeloma . American Journal of Hematology, 2021, 96 (4), pp.418 - 427 . ⟨10.1002/ajh.26083⟩
- Kaufman Jonathan, Gasparetto Cristina, Schjesvold Fredrik, Moreau Philippe, Touzeau Cyrille, Facon Thierry, Boise Lawrence, Jiang Yanwen, Yang Xiaoqing, Dunbar Fengjiao, Vishwamitra Deeksha, Unger Stefanie, Macartney Tammy, Pesko John, Yu Yao, Salem Ahmed, Ross Jeremy, Hong Wan‐jen, Maciag Paulo, Pauff James, Kumar Shaji. Targeting BCL ‐2 with venetoclax and dexamethasone in patients with relapsed/refractory t(11;14) multiple myeloma. American Journal of Hematology, 2021, 96 (4), pp.418 - 427. ⟨10.1002/ajh.26083⟩
|